The study revealed that aptamer-modified BSA NPs presented higher cellular uptake and inhibitory effect against MCF-7 cancer cells compared to non-targeted nanoparticles, due to the specific recognition of AS1411 by nucleolin overexpressed on tumor cells. The gene discussed is NUCLEOLIN; the disease is cancer.